Bayview Legacy LLC sells Arteris shares in plan

Arteris, Inc. major holder Bayview Legacy, LLC reported selling common stock in multiple open-market transactions.

Rhea-AI Filing Summary

Arteris, Inc. major holder Bayview Legacy, LLC reported selling common stock in multiple open-market transactions. On July 1, 2026, Bayview executed four sales totaling 181,338 shares of Arteris common stock at weighted average prices between $44.0606 and $47.0752.

The trades were carried out under a pre-arranged Rule 10b5-1 trading plan adopted by K. Charles Janac, who manages Bayview Legacy, LLC and is deemed to have voting and dispositive power over the shares.

Insider Trade Summary 10b5-1

Net Seller: 181,338 shares

Net Sell 4 txns

Insider Bayview Legacy, LLC

Role 10% Owner

Sold 181,338 shs ($8.24M)

Type	Security	Shares	Price	Value
Sale	Common Stock	27,691	$45.0395	$1.25M
Sale	Common Stock	63,562	$44.0606	$2.80M
Sale	Common Stock	49,680	$46.1653	$2.29M
Sale	Common Stock	40,405	$47.0752	$1.90M

Holdings After Transaction: Common Stock — 8,747,733 shares (Indirect, See Footnote)

Footnotes (7)

1. F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.
2. F2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
3. F3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.68 to $45.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. F4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
5. F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.68 to $44.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. F6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.68 to $46.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. F7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.68 to $47.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Total shares sold: 181,338 shares Transaction count: 4 sales Weighted avg price 1: $47.0752/share +3 more

6 metrics

Total shares sold 181,338 shares Net open-market sales on July 1, 2026

Transaction count 4 sales Non-derivative open-market transactions

Weighted avg price 1 $47.0752/share One of four reported sale prices

Weighted avg price 2 $46.1653/share One of four reported sale prices

Weighted avg price 3 $45.0395/share One of four reported sale prices

Weighted avg price 4 $44.0606/share One of four reported sale prices

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, beneficial ownership, voting and dispositive power, +1 more

5 terms

Rule 10b5-1 trading plan financial

"Transaction made pursuant to a 10b5-1 trading plan that was adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

beneficial ownership financial

"reporting the same transaction given his beneficial ownership of the reported security"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

voting and dispositive power financial

"is deemed to have voting and dispositive power over the shares"

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Bayview Legacy, LLC report for Arteris (AIP)?

Bayview Legacy, LLC reported selling 181,338 shares of Arteris common stock in four open-market transactions. The trades occurred on July 1, 2026, and were executed at weighted average prices between $44.0606 and $47.0752 per share.

Were Bayview Legacy, LLC’s Arteris (AIP) share sales pre-planned?

Yes. The Arteris share sales were made under a Rule 10b5-1 trading plan adopted on December 12, 2025. Such plans allow insiders to schedule trades in advance, helping separate routine portfolio management from discretionary market timing.

How many individual transactions did Bayview Legacy, LLC execute in Arteris (AIP)?

Bayview Legacy, LLC executed four separate open-market sale transactions in Arteris common stock. Each transaction was reported with its own weighted average sale price, reflecting multiple trades within specified price ranges on the same trading date.

What sale prices did Bayview Legacy, LLC receive for Arteris (AIP) shares?

The reported weighted average sale prices were $47.0752, $46.1653, $45.0395, and $44.0606 per share. Each figure represents multiple underlying trades executed within narrow price ranges disclosed in the accompanying Form 4 footnotes.

Who controls Bayview Legacy, LLC in relation to Arteris (AIP) shares?

Bayview Legacy, LLC is managed by K. Charles Janac, who is deemed to have voting and dispositive power over its Arteris shares. Janac separately filed a Form 4 reporting beneficial ownership of the same securities through Bayview Legacy, LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		S(1)(2)		27,691	D	$45.0395(3)	8,901,380	I	See Footnote(4)
Common Stock	07/01/2026		S(1)(2)		63,562	D	$44.0606(5)	8,837,818	I	See Footnote
Common Stock	07/01/2026		S(1)(2)		49,680	D	$46.1653(6)	8,788,138	I	See Footnote
Common Stock	07/01/2026		S(1)(2)		40,405	D	$47.0752(7)	8,747,733	I	See Footnote

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.68 to $45.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.68 to $44.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.68 to $46.67 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

7. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.68 to $47.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ K. Charles Janac	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)